By a 51–0 vote, the House Energy and Commerce Committee in July passed H.R. 2810, legislation that would repeal the Sustainable Growth Rate (SGR) formula. (posted Sept. 9, 2013)
Why I Advocate for Arthritis: A Rheumatologist’s Perspective
Chris Morris, MD, on why lobbying Congress is critical to maintain physicians’ ability to provide quality care to rheumatology patients
American College of Rheumatology Backs Bill to Prevent Cuts to Infusion Reimbursement
The ACR has endorsed a proposed law that would exempt physician-administered drugs from future Medicare sequestration. (posted Aug. 21, 2013)
Why I Advocate for Arthritis: A Patient’s Perspective
Reverend Anthony J. Hillelson, who has rheumatoid arthritis, on why he lobbies Congress to support rheumatic disease research funding
Congress Considers More Regulation for Manufacturers of Compounding Drugs
New legislation would place manufacturers of compounding drugs under FDA supervision. (posted July 22, 2013)
President’s Perspective: Will the Physician Payment Sunshine Act Shed Light on Conflicts of Interest?
What rheumatologists should know about complying with the PPSA when it goes into effect on August 1
How Rheumatologists Can Connect with Congress during August Recess
Tips for scheduling an in-person meeting and issues to discuss with lawmakers at their district offices
What Rheumatologists Need to Know About the Physician Payment Sunshine Act
The federal act mandates transparency within physician–industry relationship
Apply to Attend the ACR’s Advocates for Arthritis Day
Event educates legislators about the impact of rheumatic diseases and the importance of care provided by rheumatology professionals
Speak Out Rheum: How the U.K. and U.S. Healthcare Models Stack Up
A national, socialized medical system has significant advantages over the often-fragmented, unequally distributed U.S. system of healthcare, says one rheumatologist
- « Previous Page
- 1
- …
- 65
- 66
- 67
- 68
- 69
- …
- 86
- Next Page »